Antibiotics prescribed before, during and after pregnancy in the Netherlands: A drug utilization study

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 1, 2014, Pages 60-68

  De Jonge, Linda ^a   Bos, H Jens ^b   van Langen, Irene M ^a   de Jong van den Berg, Lolkje T W ^b   Bakker, Marian K ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Amoxicillin; Antibacterials; Antibiotics; Community pharmacy; Pharmacoepidemiology; Pregnancy; Prescriptions; Safety

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; PENICILLIN DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM;

ARTICLE; DRUG CLASSIFICATION; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HUMAN; NETHERLANDS; PHARMACY; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TREND STUDY;

AMOXICILLIN; ANTIBACTERIALS; ANTIBIOTICS; COMMUNITY PHARMACY; PHARMACOEPIDEMIOLOGY; PREGNANCY; PRESCRIPTIONS; SAFETY;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; NETHERLANDS; POPULATION SURVEILLANCE; POSTNATAL CARE; PREGNANCY; PRENATAL CARE;

EID: 84891630344     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3492     Document Type: Article

References (39)

1. Vazquez JC, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev 2011; 1: CD002256.
2. Lumbiganon P, Laopaiboon M, Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol 2010; 22: 95-99.
3. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007; 2: CD000490.
4. Petersen I, Gilbert R, Evans S, et al. Oral antibiotic prescribing during pregnancy in primary care: UK population-based study. J Antimicrob Chemother 2010; 65: 2238-2246.
5. Crider KS, Cleves MA, Reefhuis J, et al. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009; 163: 978-985.
6. Engeland A, Bramness JG, Daltveit AK, et al. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 2008; 65: 653-660.
7. Hardy JR, Leaderer BP, Holford TR, et al. Safety of medications prescribed before and during early pregnancy in a cohort of 81 975 mothers from the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006; 15: 555-564.
8. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet and Gynec 2004; 191: 398-407.
9. Egen-Lappe V, Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004; 60: 659-666.
10. Donati S, Baglio G, Spinelli A, et al. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol 2000; 56: 323-328.
11. Czeizel AE, Rockenbauer M, Olsen J. Use of antibiotics during pregnancy. Eur J Obstet Gynecol Reprod Biol 1998; 81: 1-8.
12. Collaborative group on drug use in pregnancy (CGDUP). Medication during pregnancy: an intercontinental cooperative study. Int J Gynecol Obstet 1992; 39: 185-196.
13. Amann U, Egen-Lappe V, Strunz-Lehner C, et al. Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf 2006; 15: 327-337.
14. 2 production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome. J Clin Microbiol 2009; 42: 713-717.
15. Jones B, Peake B, Morris AJ, et al. Escherichia coli: a growing problem in early onset neonatal sepsis. Aust N Z J Obstet Gynaecol 2004; 44: 558-561.
16. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinato 2003; 20: 405-414.
17. Nuchprayoon I, Sanpavat S, Nuchprayoon S. Glucose-6-phosphate dehydrogenase (G-6-PD) mutation in Thailand: G6PD Viangchan (871GA) is the most common deficiency variant in the Thai population. Hum Mutat 2002; 19: 185.
18. Einarson A, Shuhaiber S, Koren G. Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 2001; 3: 803-816.
19. Hernandez-Diaz S, Werler MM, Walker AM, et al. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608-1614.
20. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338: 1128-1137
21. IADB. http://iadb.nl (2010 version).
22. Visser ST, Schuiling-Veninga CCM, Bos HJ, et al. The population-based prescription database IADB.nl; its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res 2013; 13: 285-292.
23. Tobi H, van den Berg PB, De Jong-van den Berg LTW. The Interaction Database: synergy of science and practice in pharmacy. In Medical Data Analysis, Brause RW, Hanisch E (eds). Springer-Verlag: Berlin; 2000; pp. 206-211.
24. Monster TBM, Janssen WM, de Jong PE, et al. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379-384.
25. Schirm E, Tobi H, De Jong-van den Berg LT. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol 2004; 57: 737-741.
26. http://www.whocc.no/atcddd.
27. http://www.whocc.no/ddd/definition_and_general_considera/ [27 March 2013].
28. Therapeutic Goods Administration; Australian Drug Evaluation Committee; Prescribing Medicines in Pregnancy. An Australian Categorisation of Risk of Drug Use in Pregnancy, (4th edn), 1999.
29. Goossens H, Ferech M, Vander Stichele R, et al. for the ESAC project group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-587.
30. Elseviers MM, Ferech M, Vander Stichele RH, et al. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 2007; 16: 115-123.
31. Lacroix I, Hurault C, Sarramon MF, et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 2009; 65: 839-846.
32. Olesen C, Steffensen FH, Nielsen GL, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 1999; 55: 139-144.
33. Degener JE, Manson WL. Reservemiddelen bij antibioticumresistentie in het ziekenhuis. Geneesmiddelenbulletin 1998; 32: 15-21. Also accessible at http://gebu.artsennet.nl/Archief/Tijdschriftartikel/Reservemiddelen-bij-antibioticumresistentie-in-het-ziekenhuis.htm#reserve-antibiotica_en_hun_plaatsbepaling [in Dutch].
34. Ronsmans C, Graham WJ. Lancet Maternal Survival Series steering group. Maternal mortality: who, when, where, and why. Lancet 2006; 368(9542): 1189-1200.
35. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367(9516): 1066-1074.
36. Nederlands Huisartsen Genootschap (NHG); NHG-standaard M05: Urineweginfecties (accessible at http://nhg.artsennet.nl/kenniscentrum/k_richtlijnen/k_nhgstandaarden/Samenvattingskaartje-NHGStandaard/M05_svk.htm) [in Dutch].
37. Bakker M, Jentink J, Vroom F, et al. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 2006; 113: 559-568.
38. Vroom F, van Roon EN, van den Berg PB, et al. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy-a descriptive study. Pharmacoepidemiol Drug Saf 2008; 17: 52-61.
39. Stichting Perinatale Registratie Nederland. Grote Lijnen 10 jaar Perinatale Registratie Nederland Utrecht: Stichting Perinatale Registratie Nederland, 2011 also available on: http://www.perinatreg.nl/uploads/173/123/10_jaar_Perinatale_Zorg_in_Nederland_de_grote_lijnen.PDF [27 June 2013].